- Wealth PMS
This is a Capital Mind Premium post, sent on April 26, 2014.
Strides Arcolab has seen a surge in its stock price on news that the FDA continues its approvalfor Strides’ Bangalore oral dosage facility. It has gone up 12 to Rs. 526.
Note: Ignore the fall (it’s the dividend adjustment).
We have purchased Strides in the Capital Mind Premium portfolio in December,